Clinical Trials

All federally and privately supported clinical trials listed in the registry of clinical trials at are eligible for a Clinical Trial F&A rate.

UPDATE: Effective 9-1-2018, the clinical trial IDC rate will be 38%, applied to the project’s total direct costs.

Other clinical trials must meet the following conditions to qualify for the Clinical Trial F&A rate:

  1. The trial involves:
    • The testing of investigational new drugs, devices, treatments, interventions or diagnostics, or alternative indications of approved drugs, devices, treatments, interventions or diagnostics, or
    • The collection or review of data generated or acquired in a clinical setting for the purpose of assessing the safety, efficacy, benefits, costs, adverse reactions or outcomes; and
  2. Contact with human subjects or the review of patient care clinical data;
  3. Performed in an off-campus clinical setting or patient care facility; and
  4. Funded by an industry sponsor.

Preclinical laboratory studies or studies in animals are not included under the term clinical trial.

Pertinent Office(s):

See more below...